Results 111 to 120 of about 88,264 (269)

Second primary cancers in lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia—cumulative burden without generalized excess cancer risk

open access: yesBritish Journal of Haematology, EarlyView.
Summary Second primary cancers (SPCs) are a survivorship concern in lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia (LPL/WM), but estimates may be influenced by competing mortality and surveillance. We assessed cumulative incidence, relative risk and predictors of SPCs. We studied 521 patients diagnosed with LPL/WM in Region Zealand, Denmark,
Lars Munksgaard   +2 more
wiley   +1 more source

Comparative Assessment of Machine Learning and Neural Network Models for Asbestos–Cement Detection in VNIR Images

open access: yesDigital
Hyperspectral imaging is a well-established remote sensing technique for material detection and classification, relying on hundreds of reflectance bands to exploit the spectral signatures of surface materials.
Gabriel Elías Chanchí-Golondrino   +4 more
doaj   +1 more source

Minimal residual disease–guided ibrutinib and venetoclax in patients with chronic lymphocytic leukaemia and complex karyotype

open access: yesBritish Journal of Haematology, EarlyView.
Minimal residual disease (MRD)–guided ibrutinib and venetoclax (IVen) achieved durable remissions and high undetectable MRD (uMRD) rates in patients with high‐risk chronic lymphocytic leukaemia (CLL). Compared with historical ibrutinib monotherapy, IVen was associated with improved progression‐free and overall survival despite presence of complex ...
Maria Kislova   +15 more
wiley   +1 more source

Trends and socio‐economic disparities in chronic lymphocytic leukaemia 2014–2022: An England‐wide cohort study from the UNCOVER group

open access: yesBritish Journal of Haematology, EarlyView.
Summary To re‐evaluate chronic lymphocytic leukaemia (CLL) epidemiology in the era of modern therapy, data were extracted from the English National Cancer Registration Dataset (NCRD). A total of 34 427 consecutive diagnoses of CLL were recorded (2014–2022), the largest European dataset on record.
Temitope Erinfolami   +18 more
wiley   +1 more source

Correlation between the expression of CD32 and CD180 receptors on CLL cells and MEC1 cell line

open access: yes, 2015
Chronic Lymphocytic Leukemia (CLL) presents with clonal expansion and accumulation of CD5+CD19+CD23+ cells in peripheral lymphoid organs and tissues and in bone marrow. CLL is supposedly driven by exogenous and/or endogenous (auto)antigen(s) and there is
Mitskevich, N.   +3 more
core  

sj-docx-1-cll-10.1177_09636897241242624 – Supplemental material for Optimization of Xenografting Methods for Generating Human Skeletal Muscle in Mice

open access: yes
Supplemental material, sj-docx-1-cll-10.1177_09636897241242624 for Optimization of Xenografting Methods for Generating Human Skeletal Muscle in Mice by Andrea O’Neill, Anna Llach Martinez, Amber L.
Maureen A. Kane (247626)   +7 more
core   +1 more source

Predicted microbiome‐associated metabolic pathways are linked to immune checkpoint modulation in chronic lymphocytic leukaemia

open access: yesBritish Journal of Haematology, EarlyView.
Summary Microbial metabolites are key regulators of host immunity, yet their functional impact in chronic lymphocytic leukaemia (CLL) remains unclear. Following up on our earlier observations of microbiome dysbiosis in CLL, we performed predictive metabolic profiling based on 16S ribosomal RNA (rRNA) sequencing of oral and stool samples collected from ...
Monika Szelest   +15 more
wiley   +1 more source

Ibrutinib-Induced Skin Rash

open access: yesTurkish Journal of Hematology, 2021
Sudhir Kirar   +3 more
doaj   +1 more source

Development and validation of a model for stratifying haematological malignancy risk in primary care using basic blood tests

open access: yesBritish Journal of Haematology, EarlyView.
Summary Haematological malignancies are rare in primary care and are hard to predict. Existing prediction models often require a specific working diagnosis and are based on extensive clinical information, access to which may be limited at initial work‐up in primary care.
Mathilde Egelund Christensen   +9 more
wiley   +1 more source

Biomarkers Predicting Sustained Unresponsiveness After Oral Immunotherapy in the OPIA Trial

open access: yes
Allergy, EarlyView.
Duan Ni   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy